# UNH — baseline

## Metadata

ticker: UNH
arm: baseline
judge_prompt_version: v2
context_sha256: 5727937a2d459c5b27fa8aac6947c6f7549c0c1fd9699d185cce857e9d946b84
llm_calls: 7
llm_endpoints: anthropic
llm_by_site: {"rag:highlights": {"calls": 1, "completion_tokens": 311, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 3.881, "latency_s_total": 3.881, "parse_failure": 0, "prompt_tokens": 3273, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "rag:risks": {"calls": 1, "completion_tokens": 393, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 5.049, "latency_s_total": 5.049, "parse_failure": 0, "prompt_tokens": 3261, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:financial_health": {"calls": 1, "completion_tokens": 204, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.643, "latency_s_total": 2.643, "parse_failure": 0, "prompt_tokens": 813, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:recent_developments": {"calls": 1, "completion_tokens": 185, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.479, "latency_s_total": 2.479, "parse_failure": 0, "prompt_tokens": 806, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:risk_factors": {"calls": 1, "completion_tokens": 198, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 2.419, "latency_s_total": 2.419, "parse_failure": 0, "prompt_tokens": 467, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:sec_filing_highlights": {"calls": 1, "completion_tokens": 129, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 1.5, "latency_s_total": 1.5, "parse_failure": 0, "prompt_tokens": 393, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "synthesis": {"calls": 1, "completion_tokens": 1251, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 18.434, "latency_s_total": 18.434, "parse_failure": 0, "prompt_tokens": 1838, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}}

## Retrieved source context

STOCK DATA:
{
  "ticker": "UNH",
  "company_name": "UnitedHealth Group Incorporated",
  "current_price": 378.58,
  "currency": "USD",
  "market_cap": 339811434496.0,
  "pe_ratio": 24.34598,
  "forward_pe": 16.743778,
  "week_52_high": 461.62,
  "week_52_low": 255.97,
  "financial_currency": "USD",
  "revenue": 450525986816.0,
  "net_income": 14122000384.0,
  "profit_margin_pct": 3.14,
  "dividend_yield": 2.45,
  "sector": "Healthcare",
  "industry": "Healthcare Plans"
}

NEWS ARTICLES:
[
  {
    "title": null,
    "source": null,
    "published_at": null,
    "description": null
  }
]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-03-02",
    "summary": "ITEM 1A. RISK FACTORS CAUTIONARY STATEMENTS The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201canticipate,\u201d \u201cforecast,\u201d \u201coutlook,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cshould\u201d or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the \u201csafe harbor\u201d provisions of the PSLRA"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-10",
    "summary": "ITEM 1A. RISK FACTORS In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, \u201cRisk Factors\u201d of our 2025 10-K, which could materially affect our business, financial condition or future results. The risks described in our 2025 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results. There have been no material changes to the risk factors as disclosed in our 2025 10-K. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Issuer Purchases of Equity Securities (a) Second Quarter 2026 For the Month Ended Total Number of Shares Pu"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] I cannot provide a summary of the latest 10-K and 10-Q based on the information provided. The context materials only contain excerpts from a 10-K filing focused specifically on risk factors related to UNH (UnitedHealth Group), not a comprehensive overview of the full 10-K or any 10-Q filing.

The available information addresses several key risk areas:

**Medical Cost Management Risks**: The company faces challenges in accurately predicting and pricing for medical costs, as risk-based products represent nearly 80% of total revenues. Small variances between predicted and actual costs can significantly impact financial results.

**Cybersecurity and Data Security Risks**: The company processes large amounts of sensitive data and faces ongoing cybersecurity threats, including a 2024 cyberattack on the Change Healthcare business. Data breaches could result in operational disruptions, financial losses, and reputational harm.

**Technology and Systems Integration Risks**: The company must successfully consolidate and integrate information systems while keeping pace with evolving technologies, including artificial intelligence. Failures in these areas could result in higher costs and operational problems.

**Regulatory and Compliance Risks**: Rapidly evolving regulations related to health data, health information technologies, and AI may impose new compliance requirements and affect competitive positioning.

To obtain a complete summary of the latest 10-K and 10-Q filings, you would need to review the full documents directly.

RAG — RISK FACTORS:
[From Pinecone cache] # Primary Risk Factors Disclosed

The company discloses several significant risk factors affecting its business:

## Medical Cost Management and Pricing Risks
The company assumes medical and administrative costs through risk-based benefit products, which constitute nearly 80% of total consolidated revenues. Key risks include the inability to accurately estimate, price for, and manage medical costs. Small differences between predicted and actual medical costs can result in significant financial impacts. Various factors may cause actual costs to exceed estimates, including:
- Medical cost inflation
- Increased use of services and provider billing intensity
- Unexpected differences among new customer populations
- Introduction of new or costly drugs and price increases
- Large-scale medical emergencies and pandemics
- Climate change effects
- New treatment guidelines and regulatory changes

## Information Systems and Technology Risks
The company depends on data integrity and availability for operations. Risks include:
- Inaccurate, incomplete, or unreliable data affecting health, wellness, and technology products
- Failure to properly consolidate, integrate, upgrade, or expand information systems
- Technology products not operating as intended
- Challenges in keeping pace with evolving technologies, including artificial intelligence
- Software products containing design defects or installation complications

## Cybersecurity and Data Security Risks
The company regularly processes large amounts of protected personal information and proprietary data. Significant risks include:
- Cyberattacks and data security incidents causing operational disruption
- Misappropriation or disclosure of protected health information
- Evolving cyber threats using sophisticated techniques and AI technologies
- Vulnerabilities in third-party vendor systems
- Potential financial and reputational harm from security breaches

## Business Relationship Risks
The company faces risks related to maintaining satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers.

## Pre-written sections (judge input)

### Financial Health

UnitedHealth Group trades at $378.58 with a substantial market capitalization of $339.8 billion, reflecting its position as a healthcare industry leader. The company generated $450.5 billion in revenue with a net profit margin of 3.14%, yielding $14.1 billion in net income, demonstrating solid operational scale despite modest profitability typical of healthcare plans. The current P/E ratio of 24.3x appears elevated relative to the forward P/E of 16.7x, suggesting market expectations for earnings growth or potential valuation compression. With a 2.45% dividend yield and recent 52-week trading range of $255.97–$461.62, UNH exhibits both income appeal and significant volatility. Overall, the company presents a financially stable profile with strong revenue generation, though investors should monitor the valuation multiple and margin pressures inherent in the healthcare sector.

### Recent Developments

UnitedHealth Group's most recent SEC filings show no material changes to previously disclosed risk factors as of the second quarter 2026, suggesting operational stability in the healthcare plans segment. The company continues to execute share repurchase programs, with activity noted in Q2 2026, supporting shareholder returns alongside its 2.45% dividend yield. With a forward P/E of 16.74 compared to the current P/E of 24.35, the valuation suggests market expectations for earnings growth, though investors should monitor regulatory and competitive pressures inherent to the healthcare industry. The 3.14% profit margin reflects the capital-intensive nature of health plan operations, while the stock's recovery from its 52-week low of $255.97 to $378.58 indicates investor confidence in the company's strategic positioning.

### SEC Filing Highlights

UnitedHealth Group faces significant medical cost management risks, with risk-based products comprising nearly 80% of revenues, making accurate cost prediction critical to financial performance. The company experienced a notable 2024 cyberattack on its Change Healthcare business, underscoring ongoing cybersecurity vulnerabilities associated with processing large volumes of sensitive healthcare data. Technology integration challenges persist as UNH consolidates systems and adapts to emerging technologies including artificial intelligence. Rapidly evolving regulatory requirements around health data, information technology, and AI present compliance risks that could impact competitive positioning and operational costs.

### Risk Factors

• **Medical Cost Management Risk**: UNH assumes medical and administrative costs through risk-based products representing ~80% of revenues. Small variances between predicted and actual medical costs can significantly impact profitability, with exposure to medical inflation, unexpected service utilization, new drug costs, pandemics, and regulatory changes.

• **Cybersecurity and Data Security Risk**: As a processor of large volumes of protected health information and proprietary data, UNH faces ongoing threats from cyberattacks, data breaches, and third-party vendor vulnerabilities that could result in operational disruption, regulatory penalties, and reputational damage.

• **Technology and Information Systems Risk**: UNH's operations depend on data integrity and system reliability. Risks include system integration failures, technology products not performing as intended, and challenges in adopting emerging technologies like artificial intelligence, which could impair product functionality and competitive positioning.

## Audited (Exec Summary + Outlook)

### Executive Summary
UnitedHealth Group is a healthcare industry leader operating at substantial scale, generating $450.5 billion in revenue and $14.1 billion in net income while commanding a market capitalization of $339.8 billion. The stock is notable now because of a meaningful gap between its current P/E of 24.3x and forward P/E of 16.7x, a wide 52-week trading range of $255.97–$461.62 that reflects elevated uncertainty, and lingering investor scrutiny following the 2024 Change Healthcare cyberattack — all of which create a complex risk-reward picture for prospective buyers. The single most important near-term variable is medical cost management: with risk-based products comprising nearly 80% of revenues, any meaningful divergence between predicted and actual medical costs has an outsized and direct impact on the company's already-thin 3.14% net profit margin.

### Outlook
The directional lean on UNH is **cautiously constructive**, contingent on execution. The primary tailwind is the company's entrenched scale and diversified healthcare platform, which supports durable revenue generation and continued shareholder returns through dividends and buybacks. The forward P/E sitting meaningfully below the current P/E suggests the market is pricing in earnings improvement — but that improvement is far from guaranteed. Investors should watch the medical cost trend above all else: sustained or worsening medical inflation, unexpected utilization spikes, or adverse drug cost developments could compress the already-thin profit margin and erode the earnings growth thesis that underpins the current valuation. On the regulatory front, evolving requirements around health data, AI, and information technology represent a slow-moving but real headwind that could raise compliance costs and constrain competitive flexibility. Cybersecurity posture deserves ongoing scrutiny as well — a repeat or escalation of the type of incident seen with Change Healthcare in 2024 could trigger regulatory penalties, reputational damage, and operational disruption simultaneously. What would strengthen the thesis: demonstrated improvement in medical cost predictability, successful AI and technology integration that drives efficiency, and a stable or favorable regulatory environment. What would weaken it: margin deterioration driven by cost surprises, a significant new cybersecurity event, or regulatory actions that structurally impair the health plans business.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically audit every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the **Executive Summary** and **Outlook** sections.

---

## EXECUTIVE SUMMARY

---

CLAIM: "$450.5 billion in revenue"
LABEL: SUPPORTED
REASON: Source data shows revenue of $450,525,986,816, which rounds to $450.5 billion; the Financial Health pre-written section also states "$450.5 billion in revenue."

---

CLAIM: "$14.1 billion in net income"
LABEL: SUPPORTED
REASON: Source data shows net income of $14,122,000,384, which rounds to $14.1 billion; confirmed in the Financial Health section.

---

CLAIM: "market capitalization of $339.8 billion"
LABEL: SUPPORTED
REASON: Source data shows market_cap of $339,811,434,496, which rounds to $339.8 billion; confirmed in the Financial Health section.

---

CLAIM: "current P/E of 24.3x"
LABEL: SUPPORTED
REASON: Source data shows pe_ratio of 24.34598, which rounds to 24.3x; confirmed in the Financial Health section.

---

CLAIM: "forward P/E of 16.7x"
LABEL: SUPPORTED
REASON: Source data shows forward_pe of 16.743778, which rounds to 16.7x; confirmed in the Financial Health section.

---

CLAIM: "52-week trading range of $255.97–$461.62"
LABEL: SUPPORTED
REASON: Source data shows week_52_low of $255.97 and week_52_high of $461.62, matching exactly.

---

CLAIM: "risk-based products comprising nearly 80% of revenues"
LABEL: SUPPORTED
REASON: The RAG Risk Factors section explicitly states "risk-based benefit products, which constitute nearly 80% of total consolidated revenues," and this is echoed in both the SEC Filing Highlights and Risk Factors pre-written sections.

---

CLAIM: "3.14% net profit margin"
LABEL: SUPPORTED
REASON: Source data shows profit_margin_pct of 3.14, matching exactly; confirmed in the Financial Health section.

---

## OUTLOOK

---

CLAIM: "The forward P/E sitting meaningfully below the current P/E"
LABEL: SUPPORTED
REASON: Forward P/E is 16.7x vs. current P/E of 24.3x — a difference of approximately 7.6 points, which arithmetically confirms the forward P/E is meaningfully below the current P/E.

---

CLAIM: "a repeat or escalation of the type of incident seen with Change Healthcare in 2024"
LABEL: SUPPORTED
REASON: The RAG SEC Highlights and SEC Filing Highlights pre-written section both explicitly reference "a 2024 cyberattack on the Change Healthcare business."

---

*(No additional quantitative figures, price targets, thresholds, ratios, metrics, percentages, named product milestones, or forward-looking numbers appear in the Outlook section beyond those already audited above or restated directionally without specific figures.)*

---

### Summary Table

| Claim | Label |
|---|---|
| $450.5 billion in revenue | SUPPORTED |
| $14.1 billion in net income | SUPPORTED |
| Market cap of $339.8 billion | SUPPORTED |
| Current P/E of 24.3x | SUPPORTED |
| Forward P/E of 16.7x | SUPPORTED |
| 52-week range $255.97–$461.62 | SUPPORTED |
| ~80% of revenues from risk-based products | SUPPORTED |
| 3.14% net profit margin | SUPPORTED |
| Forward P/E meaningfully below current P/E | SUPPORTED |
| Change Healthcare 2024 cyberattack reference | SUPPORTED |

**All audited claims are SUPPORTED.** No unsupported or inference-only quantitative claims were identified in the Executive Summary or Outlook sections.
